ライフサイエンスコーパス: describe

1 ctive total synthesis of (-)-deoxoapodine is described.

2 Rhodesian Ridgeback dogs (6 wk to 18 mo) are described.

3 and alpha-nucleophiles into biomolecules are described.

4 struction of novel tetracyclic compounds was described.

5 ohols under metal-free and mild condition is described.

6 vironmental and diseases analysis fields are described.

7 ation of (2S)-2-chloro-2-fluorolactone 29 is described.

8 -allylic phosphate tethered to an alkyne are described.

9 newly identified CD247-deficient patient are described.

10 N-amination and N-azo coupling reactions is described.

11 trifluoroacetate salts from aryl iodides is described.

12 f known period of burial and age at death is described.

13 with high CD4 cell counts have not been well described.

14 and nitriles in the presence of BF3.OEt2 is described.

15 sed-beta-lactones from N-linked ketoacids is described.

16 orbidity of survivors, however, has not been described.

17 both batch and continuous flow conditions is described.

18 's reagent to widely available azlactones is described.

19 s high, but the causes of death are not well described.

20 lic substitution of aryl C-OMe bond has been described.

21 of care that drive this increase are poorly described.

22 ld with fused tetrahydroquinoxaline rings is described.

23 The degradation of geminal diazides is described.

24 pediatric clinic visit prior to transfer was described.

25 dulans SPBs and septum-associated MTOCs were described.

26 ment metrics used in RNA-Puzzles are briefly described.

27 quired pharmacogenomic biomarker testing, we describe 1) the use of enrichment (biomarker-positive pa

28 We describe a cellular reporter to directly monitor the phe

29 Here, we describe a combined biological/enzymatic synthesis that

30 Here, we describe a CRISPR affinity purification in situ of regul

31 Here we describe a detailed protocol based on covalent binding o

32 Here we describe a detailed protocol that describes how to initi

33 Here, we describe a family with Liddle syndrome due to a mutation

34 Here, we describe a generalizable platform to create dual-FP bios

35 Here, we describe a high-throughput method for rapid identificati

36 Here we describe a measurement platform that allows for the comb

37 In summary, we describe a mechanism by which increased cytosolic Ca(2+)

38 Herein, we describe a mechanism whereby DNA and associated DNABII p

39 Here we describe a medicinal chemistry program starting from ami

40 We describe a microfluidic device that isolates and enumera

41 Here we describe a microfluidic DNA preconcentration technique t

42 Here we describe a molecular system that can be programmed to co

43 Here, we describe a mouse strain lacking the E3 ubiquitin ligase

44 Here we describe a new, exquisitely three-dimensionally preserve

45 Finally, we describe a novel form of activity-dependent intrinsic pl

46 We describe a novel method of kinetic analysis of radioliga

47 We describe a novel representative of the widespread uncult

48 Here we describe a parasite-specific transcription factor PfAP2-

49 Here we describe a phosphoproteomics workflow to examine the eff

50 Here we describe a platform for identifying target-binding cysti

51 Here we describe a protocol to generate expandable and multipote

52 Here, we describe a rapid, inexpensive, and portable strategy to

53 We describe a refined and accessible method to non-subjecti

54 Here we describe a reporter cell-based assay to quantify inducib

55 We describe a robust statistical approach to identify loci

56 Herein, we describe a simple, selective, and mild procedure for the

57 To describe a skin cancer screening quality initiative in a

58 Here, we describe a structure we refer to as the embryo sheath th

59 Here, we describe a study done in the Lake Superior-Saint Louis R

60 We describe a three-tissue organ-on-a-chip system, comprise

61 Here, we describe a unique role for the orphan catalytic subunit

62 Herein, we described a novel type of smart probes with tunable reac

63 We recently described a novel, near-physiological organoid culture s

64 The canonical model of DNA replication describes a highly-processive and largely continuous pro

65 This Communication describes a new molecular design that yields ultranarrow

66 The present work describes a novel HPLC and UV-spectrophotometric method

67 Paramutation describes a process that results in heritable epigenetic

68 Our study describes a retinal dystrophy-related phenotype spectrum

69 This framework describes a suite of algorithms by which a model of the

70 This article describes a suite of services and web applications that

71 This protocol describes a unique in vitro method for the generation of

72 ange (vdW-DF-C09), which has been applied to describing a wide range of dispersion-bound systems, we

73 DSM-5 describes "a distinct period of abnormally and persisten

74 subnetworks built from the three algorithms described above were comparatively appraised in terms of

75 Graduates described accommodating strategies where they modified a

76 s tended to focus on the synapse, where well-described activity-dependent mechanisms are known to pla

77 y diseases (PIDs) where reversions have been described also revealed a higher rate of mutation than t

78 Most nucleation theories used to describe amyloid aggregation predict low oligomer concen

79 Lastly, we describe an analogous Foxa2+ population during different

80 Here, we describe an automated clustering approach and associated

81 In this work, we describe an electronics-based Enzyme-Linked ImmunoSorben

82 Here we describe an enhanced fluorescence fluctuation imaging an

83 Treeline responses to environmental changes describe an important phenomenon in global change resear

84 We herein describe an innovative method for a universal fluorescen

85 We describe an intriguing tension between phenotypic comple

86 We describe an MS-based HTS workflow that addresses these c

87 To improve computational efficiency, we describe an new importance sampling scheme to perform mo

88 Here we describe an update of the database.

89 In this study, we describe and characterize novel sensors based on the Sys

90 To describe and compare the anatomical distribution of BCC

91 Here we described and analyzed a similar phenotype in POMT mutan

92 The electrodes are described and characterized herein.

93 ed, then individual TORCH infections will be described and compared with the imaging findings associa

94 C-H functionalization of alkynes, have been described and organized on the basis of the catalysts em

95 insect orders, comprising more than 153,000 described and possibly up to one million undescribed ext

96 nd Aspergillus species have been extensively described and their corresponding genetic mutations can

97 This paper describes and discusses the application of trimethylsily

98 iled comparison was made with the previously described arylimido homologues.

99 Although often described as a childhood disease, newer population-based

100 iral vector encoding Rab Escort Protein 1 is described as a part of gene therapy for choroideremia.

101 sm of Trichoderma reesei Xpp1 was previously described as a repressor of xylanases.

102 drolytic and sonochemical Pu colloids can be described as core-shell nanoparticles composed of quasi-

103 GPR44 expression has recently been described as highly beta-cell selective in the human pan

104 (NOS2) and cyclooxygenase-2 (COX2) have been described as independent predictors of disease outcome.

105 progresses, this is replaced by what we have described as maternal educational immunity such that by

106 To describe associations of ocular and systemic factors wit

107 Here, we describe B cell responses to C-PfCSP from European donor

108 Several models have been proposed to describe body sway in an upright standing position, howe

109 A few phenotypic assays have been described but have not been independently evaluated.

110 ics observed in the native membranes, and is described by a multisquare model with Schiff base deprot

111 Complex economic systems can often be described by a network, with nodes representing economic

112 180(o) commensurate magnetic domains, can be described by ferromagnetic and ferroelectric domains onl

113 methodology, related to robustness screening described by Glorius et al., builds a broad understandin

114 tuberculosis prevalence, including a method described by Rust and Thomas more than 40 years ago.

115 nds mysteriously moving around on lakes were described by several Latin authors almost two millennia

116 s and buildings in antique times is commonly described by the term antique polychromy.

117 gth-control feedback system rather than that described by the time-of-flight model.

118 l magnetism, among the many systems that are described by the XY Hamiltonian.

119 Each method described can be repeatedly performed during culture, al

120 ontext conditioning literature in humans and describe challenges to study contextual learning in huma

121 In this issue of Cancer Cell, Chen et al. describe complementary approaches demonstrating that MLL

122 ct but partially overlapping with previously described contributions of the recombination regulator C

123 This review aimed to describe core constipation symptoms and their frequency

124 In this study, we describe Cycloclasticus that have established a symbiosi

125 In this study, we describe data indicating that the yeast family members L

126 Here we describe DeActs, genetically encoded actin-modifying pol

127 The described differences underline the complementarity of N

128 the renaissance has unfolded, we attempt to describe different points of view fairly but not neutral

129 meterized with experimental imaging data, to describe doxorubicin uptake and predict subsequent popul

130 inding of a manganese oxidizing complex, and describe early stage formation of its mineral products.

131 unction of neural circuits in vivo This work describes early postnatal developmental abnormalities in

132 No national studies have described ED use rates among kidney transplant (KTx) rec

133 We describe eight patients from three independent families

134 ce and mortality, risk factors, and recently described endotypes.

135 scusses the discovery and genetics of LOX-1; describes existing evidence supporting the role of LOX-1

136 Here we describe experiments in which we studied binocular inter

137 To describe factors that predict visual loss and complicati

138 In the present study, we describe for the first time the presence of ACSL6 mRNA i

139 e RRE in a manner similar to that previously described for DDX1, although DDX3 does not.

140 ine ring (e.g., CIP product with m/z 280) is described for FQs.

141 rences for life-sustaining treatment is well described for individual clinical decisions; however, it

142 Up to 68% of the hits are chemotypes described for the first time as late-stage gametocyte-ta

143 PVN that are different from that previously described for the rat, thus, elucidating potential neuro

144 bond activation and ring-opening process is described for these increasingly important NHC molecules

145 Here, we describe functional units, at a cellular level, of a com

146 Here we describe genome-engineering based evaluation of RNA regu

147 HRAE was also assessed by using a previously described hemocompatibility score, which uses 4 escalati

148 We describe here a serum-free, artificial thymic organoid (

149 We describe here eight related individuals with autosomal r

150 We describe here important differences in how the Rb and p1

151 We describe here the first use of thiosemicarbazone exchang

152 We describe here the identification and characterization of

153 through mechanisms similar to those that we describe here.

154 ter species with Exophiala lecanii-corni are described here as Exophiala lavatrina sp.

155 The smFISH procedure described here can be completed in 4-5 d.

156 Novel concepts and paradigms are described here that have emerged, targeting superior TE

157 The approach described here to identify enhancer-associated small ins

158 The multi-SNP analysis described here was readily adopted by another laboratory

159 We describe herein its structure and replicative cycle, alo

160 site-selectivity of the aza-Michael ligation described herein allows the construction of stable secon

161 Examples described herein are the naturally occurring benzofurans

162 Described herein is that the platinum (boryl)iminomethan

163 Described herein is the preparation of oxalyl boronate b

164 Here we describe high-quality draft genomes of these two species

165 In this paper we describe HistomicsML, an interactive machine-learning sy

166 Herein, we describe how content on www.personalizedcancertherapy.or

167 Here, we describe how F-specific antibodies protect against RSV a

168 shape their differentiation and behavior and describe how macrophages change during protective immuni

169 As an example, we describe how this method can be used to covalently immob

170 Here we describe how to apply CellNet to RNA-seq data and how to

171 o unravel their role in immunology and it is described how focused libraries of TAs have been used to

172 logy, we published a Registered Report, that described how we intended to replicate selected experime

173 logy, we published a Registered Report, that described how we intended to replicate selected experime

174 Here we describe a detailed protocol that describes how to initiate the in vitro differentiation o

175 In describing how the renaissance has unfolded, we attempt

176 s and has similar properties to the recently described human epigenetic clock.

177 amily BMP antagonist gene (GREM1) originally described in Ashkenazi Jews.

178 or analyzing neuroimaging data organized and described in compliance with the Brain Imaging Data Stru

179 of M. genitalium reviewed at the meeting is described in detail in the individual articles included

180 ragm dynamics, MAGI2 mutations have not been described in human SRNS.

181 f postprotocol therapies were enumerated and described in long-term survivors.

182 of Tail-anchored proteins (GET) pathway was described in mammalian and yeast cells that serve as a b

183 Two subsets of blood monocytes are commonly described in mice and humans: the classical inflammatory

184 hrough progenitor states that have only been described in mouse.

185 cause mutations in the TUBB4A gene have been described in patients with central nervous system hypomy

186 Recently, DES mutations were described in patients with inherited arrhythmogenic righ

187 maternal smoking during pregnancy have been described in placenta and cord blood at delivery, in fet

188 a quantum picture, however, the collision is described in terms of matter waves, which can also scatt

189 had a newly detected finding of ovarian cyst described in the body or impression section of the repor

190 existing correlation and evaluative methods described in the literature.

191 atopic dermatitis, yet it has been sparsely described in the literature.

192 important inflammatory mediators previously described in the periodontitis disease.

193 In this first part of a 2-part review, we describe indications, implant-related complications, bas

194 data, to incorporate logical functions that describe interactions between regulators on downstream g

195 ELISA, two analytes (ST2 and Spondin-1) best described longitudinal change in modified Rodnan skin sc

196 The precautions and methods we describe may enable investigators to avoid confounding c

197 Finally, we show why the described mechanisms are relevant not only in hypertensi

198 The described method can provide an effective and economical

199 Here, we describe mGluR5 findings in stress disorders, particular

200 We describe modifications to an Orbitrap mass spectrometer,

201 This protocol describes multichannel time-lapse confocal imaging of an

202 , using a palette of histological methods we describe neurons and their neuropils most immediately as

203 We describe new mechanisms of coding and noncoding alterati

204 ionally emphasized empirical principles that describe nonlinear interactions between inputs from two

205 Such self-assemblies describe not only the basic structural motif of G-quadru

206 We describe opportunities and challenges in RNA structural

207 We describe optimized fragmentation schemes and data analys

208 We describe our approaches and insights on documenting and

209 rogeneous classical nucleation theory cannot describe our simulation results, because the different s

210 In this study, we describe population-level trends in the adult life expec

211 Here, we describe potential biases that arise when ABM assumption

212 Recently, we described potentiometric-scanning ion conductance micros

213 tudy for the formation of benzoquinoline was described precisely.

214 The index described previously (carbene relative energy of formati

215 Although several families with KS have been described previously, our case is noteworthy for several

216 he methods for achieving consensus have been described previously.

217 Here we describe RCB-185, a lipophilic prodrug with nanomolar ac

218 ding experimental confirmation to the theory describing reaction kinetics in a segregated flow system

219 viously considered.In this review, we aim to describe recent advances in neuropathology of MSA from a

220 In this update, we describe recent changes and additions to our website, da

221 The described regimen appears to be safe and effective for p

222 We also described risk factors for disengagement based on a Cox

223 Here we describe SGN-CD19B, a pyrrolobenzodiazepine (PBD)-based

224 The results as described shed a useful light on the reactivity, appeara

225 Here we describe ShootingStar, a platform for perturbation analy

226 Here, we describe site-selective, copper-promoted couplings of bo

227 In this article, we briefly describe some successes in predicting behaviors and desc

228 In this review, we describe speculative ideas and early stage research conc

229 We recently described that Mtb infection upregulated expression of t

230 Here, a cocktail preservative is described that stabilizes leukocyte viability and erythr

231 cule splicing modifiers have been previously described that target the general splicing machinery and

232 Here we describe the 'Asgard' superphylum, a group of uncultivat

233 In this report we describe the appearance of transgene-specific T-cell res

234 We describe the application of a standardized assay for HIV

235 We used this line to describe the assembly of the major vessels of the trunk

236 s on health, equity, and women's cancers, we describe the burden of breast and cervical cancer, with

237 ting articles showed there was a tendency to describe the cell line in accordance with the descriptio

238 ts for several significant retinal diseases, describe the challenges involved and discuss how basic d

239 e some successes in predicting behaviors and describe the challenges over the next few years.

240 With pressure-volume analysis, we separately describe the changing properties of the pulmonary vascul

241 To describe the characteristics, management, and outcome of

242 To describe the detailed clinical and molecular genetic fin

243 Here, we describe the development of an alternative vaccine strat

244 pithelium (RPE) humps in high myopia, and to describe the distinctive features from pathologic RPE de

245 eases in Africa is urgently needed to better describe the distribution of pathogen-borne diseases and

246 riables including cell lines to organize and describe the diverse experimental variables and data res

247 In this study, we describe the dual role of the transcription factor Xylan

248 We describe the effect of varying particle size and shape o

249 attempt has been made, whenever possible, to describe the enzymatic mechanisms of catalysis within th

250 To describe the evolution of a heterogeneous tumour, we eva

251 Here, we describe the FEP+ method as applied to protein stability

252 We sought to describe the frequency of reintubations across U.S. ICUs

253 ves of this study were to develop a model to describe the generation, consumption and release of heat

254 state-of-the-art of organosulfur ligands, we describe the gold-sulfur bond formation and the nature o

255 Herein we describe the identification of 4-{[1,2,4]triazolo[1,5-a]

256 To describe the impact of the globalization of medical educ

257 Here, we describe the map-based cloning of the Ms2 gene and show

258 To describe the ocular findings, visual impairment, and ass

259 This article will describe the past decade of work toward this goal and ar

260 Herein we describe the preparation of molecularly imprinted silica

261 We also describe the recently characterized meningeal lymphatic

262 Here we describe the stabilization of the heaviest 4+ ion of the

263 Using computational analysis, we describe the structural and photophysical properties of

264 We describe the structure and morphology of aggregates form

265 Here we describe the temporal orchestration of a series of metab

266 We aimed to comprehensively describe the treatment cascade for RHD in Uganda to iden

267 We have provided elaborated tables which describe the types, model specifications, sensing mechan

268 cipants viewed a 50-min movie, then verbally described the events during functional MRI, producing un

269 Herein, we described the evolution of a reported PI3K inhibitor int

270 Analyses described the incidence of major (>1000 copies/mL) and m

271 This article describes the design and some of the approaches pursued

272 This study describes the development of a comprehensive set of geno

273 This study describes the results from complementary laboratory and

274 This review describes the role of endogenous RAGE ligands/effectors

275 es an overview of RRNPP prototype signaling; describes the structure-function of this protein family,

276 The present article describes the validation of this method, which was perfo

277 This is the first report describing the ability of the pH1N1 NS1 protein to natur

278 search has looked for simple geometric rules describing the attack trajectories of animals, but the u

279 g, and intrinsic forgetting, the latter term describing the brain's chronic signaling systems that fu

280 Describing the natural course of neovascular age-related

281 to obtain detailed, quantitative information describing the relative abundance of selected noncellulo

282 ft; (2) a characteristic angular correlation describing the size of genetic domains; and (3) a dimens

283 Recently, there have been several reports describing their application to the detection of small m

284 s of congenital infections initially will be described, then individual TORCH infections will be desc

285 We describe this method using dulaglutide, a glucagon-like

286 world-wide, but long-term empirical datasets describing this condition are rare.

287 studies where clade C predominates, here we describe three virus panels, chosen from 200 well-charac

288 the recent earthquakes in Nepal has not been described thus far.

289 The only venting mechanism described to do this at an adequate rate is H(+)-coupled

290 ere we provide an overview of these factors, describe tools for measurement of ongoing transmission,

291 Here, we describe two brothers with hematopoietic and immunologic

292 We describe two new complementary approaches - stable isoto

293 Data elements were extracted and narratively described variables synthesised into four categories.

294 We describe what has been determined to date, discuss exist

295 his quantitative signal processing have been described, whereas others await discovery.

296 f four nitronyl nitroxide (NN) biradicals is described which are conjugatively linked through p-ter-p

297 f biarylpyrazole imidazole and triazoles are described, which vary in the linker between the biaryl p

298 nded, contracted, and isomeric porphyrins is described with an emphasis on the use of magnetic circul

299 k has shown that it is possible to apply the described workflows to food fraud problems, with an obje

300 elicit mucosal TH17 cell responses have been described, yet how these cells are sustained in chronica